Shares of the medical device maker Abiomed Inc. fell sharply after the Danvers company reported lower profit in the third quarter, despite posting strong sales growth. Abiomed reported third-quarter fiscal 2013 revenue of $38.3 million, up 19 percent, compared to $32.2 million in fiscal 2012, on record quarterly patient product usage. Abiomed also reported net income of $2.7 million, or 7 cents a share, compared to net income of $2.9 million, 7 cents, in fiscal 2012.
Heart device maker slumps as profit falls
Globe Staff February 07, 2013
Read it all, now.
Don't miss any of your favorite stories again. Read the stories that matter to you as much as you want, whenever you want when you subscribe to BostonGlobe.com.
Get full access today for just 99¢